N@N

Tongjitang Hosts Successful 2009 Annual General Meeting

^{Published on 2009-12-23 05:10:09 - Market Wire}
 

SHENZHEN, China--([ BUSINESS WIRE ])--Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it held its Annual General Meeting of Shareholders (AGM) for the fiscal year ended December 31, 2009 this morning at 11 a.m. (local time) in the Company's executive office located at the following address: 5th Floor, Block B, Nanshan Medical Device Park, 1019 Nanhai Avenue, Nanshan District, Shenzhen, 518067 Guangdong Province, People's Republic of China.

At the AGM, Mr. Xiaochun Wang, the Chairman of the Board of Directors and Chief Executive Officer, reported on the Company's progress during the fiscal year ended December 31, 2009. The Chairman's script has been posted online at [ www.tongjitang.com ].

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante and Anhui Jingfang, is a vertically integrated specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang's principal executive offices are located in Shenzhen, China.

Tongjitang's flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 36 other modernized traditional Chinese medicine products and 37 western medicines. Please visit [ www.tongjitang.com ] for more information.